DEA schedule

Is Xywav a controlled substance?

Xywav contains sodium oxybate, calcium oxybate, potassium oxybate and magnesium oxybate. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

Yes. Xywav (sodium oxybate, calcium oxybate, potassium oxybate and magnesium oxybate) is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Gamma Hydroxybutyric Acid preparations (Schedule III).

Run it in Rivvi

Which 2027 plans near you dropped or restricted Xywav?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Xywav
SourceWhat it lists
FDA NDC directory1 prescription listings from 1 labelers, all Schedule III
DEA controlled substances listGamma Hydroxybutyric Acid: Schedule I; Gamma Hydroxybutyric Acid preparations: Schedule III

DEA list entry

DEA list entries for sodium oxybate, calcium oxybate, potassium oxybate and magnesium oxybate
SubstanceDEA codeScheduleNarcoticOther namesMatch
Gamma Hydroxybutyric Acid2010INoGHB; gamma hydroxybutyrate; sodium oxybateIsomer or salt of the listed substance (21 CFR 1308)
Gamma Hydroxybutyric Acid preparations2012IIINoXyremListed combination or preparation
Gamma Hydroxybutyric Acid2010INoGHB; gamma hydroxybutyrate; sodium oxybateIsomer or salt of the listed substance (21 CFR 1308)
Gamma Hydroxybutyric Acid preparations2012IIINoXyremListed combination or preparation
Gamma Hydroxybutyric Acid2010INoGHB; gamma hydroxybutyrate; sodium oxybateIsomer or salt of the listed substance (21 CFR 1308)
Gamma Hydroxybutyric Acid preparations2012IIINoXyremListed combination or preparation
Gamma Hydroxybutyric Acid2010INoGHB; gamma hydroxybutyrate; sodium oxybateIsomer or salt of the listed substance (21 CFR 1308)
Gamma Hydroxybutyric Acid preparations2012IIINoXyremListed combination or preparation

Xywav NDC listings

NDC listings for Xywav
NDCProductFormStrengthLabelerDEA schedule
68727-150XYWAVsolution.5 g/mL; .5 g/mL; .5 g/mL; .5 g/mLJazz Pharmaceuticals, Inc.CIII

Questions

Is Xywav a controlled substance?

Yes. Xywav (sodium oxybate, calcium oxybate, potassium oxybate and magnesium oxybate) is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Gamma Hydroxybutyric Acid preparations (Schedule III).

Is Xywav a narcotic?

No. The DEA list does not mark sodium oxybate, calcium oxybate, potassium oxybate and magnesium oxybate as a narcotic (NARC = N) and places it in Schedule III. Its FDA established pharmacologic class is Central Nervous System Depressant.

What schedule is Xywav?

Xywav is Schedule III in the FDA NDC directory, which matches the DEA controlled substances list.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Xywav

Try it on your own data today.

Free to start. Most teams are using it the same day.